The gelatin capsule market size has grown strongly in recent years. It will grow from $4.92 billion in 2025 to $5.27 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The historical-period growth can be attributed to expansion of pharmaceutical manufacturing and oral drug delivery systems, increasing demand for convenient dosage forms, rising use of gelatin capsules in vitamins and dietary supplements, growth in global generic drug production, and improvements in capsule manufacturing technologies and automation processes.
The gelatin capsule market size is expected to see strong growth in the next few years. It will grow to $7.01 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to increasing demand for nutraceuticals and functional food products, growing shift toward plant-based and vegan capsule alternatives, rising adoption of precision medicine and controlled-release formulations, expansion of global pharmaceutical manufacturing capacity, and increasing focus on drug stability and bioavailability enhancement. Key trends in the forecast period include transition toward plant-based capsule materials replacing animal-derived gelatin, increasing adoption of modified-release capsule technologies for targeted drug delivery, rising demand for nutraceutical and dietary supplement encapsulation, integration of advanced coating technologies for moisture and oxygen protection, and growing use of high bioavailability capsule formulations in personalized medicine.
The growth of the pharmaceutical industry is expected to propel the growth of the gelatin capsule market going forward. The pharmaceutical industry refers to the sector involved in the research, development, production, and marketing of drugs used for medical treatment, prevention, and diagnosis of diseases. The expansion of the pharmaceutical industry is driven by the increasing prevalence of chronic and lifestyle-related diseases, which leads to higher demand for continuous drug development and treatment solutions. The pharmaceutical industry utilizes gelatin capsules as a reliable drug delivery system that improves stability, enhances bioavailability, ensures precise dosing, and increases patient compliance by making medicines easier to swallow and masking unpleasant tastes and odors. For instance, in April 2025, according to Eurostat, a Luxembourg-based government agency, in 2024, EU exports of medicinal and pharmaceutical products increased by 13.5% compared with 2023, reaching $316.38 billion (€313.4 billion). At the same time, imports only recorded a modest increase of 0.5%, amounting to $112.7 billion (€119.7 billion). Therefore, the pharmaceutical industry is driving the growth of the gelatin capsule market.
Leading companies operating in the gelatin capsule market are focusing on developing innovative products, such as soft gelatin capsules to improve bioavailability, enhance patient compliance, and enable easier administration of medications across all age groups. Gelatin capsules are edible, biodegradable pharmaceutical dosage forms made from animal-derived gelatin or plant-based alternatives, designed to encapsulate liquid, semi-solid, or powdered drug formulations in a smooth, swallowable shell that dissolves rapidly in the digestive tract for efficient drug release. For example, in August 2024, Geneith Pharmaceuticals Limited, a Nigeria-based pharmaceutical company, launched Coatal Forte Soft Gelatin Capsules, a patient-friendly antimalarial formulation designed to improve treatment accessibility and effectiveness. The product is available in multiple strengths, including Coatal Gelatin Soft Gel 80/480 and 20/120, offering flexible dosing options to suit different patient needs. It is formulated to ensure faster drug delivery and improved therapeutic outcomes while maintaining affordability and ease of use, making it suitable for patients across all age groups and supporting better compliance in malaria treatment regimens.
In December 2023, Amneal Pharmaceuticals Inc., a US-based specialty pharmaceutical company engaged in gelatin capsule manufacturing, entered into a partnership with Strides Pharma Science Limited to jointly develop, manufacture, and supply icosapent ethyl acid soft gelatin capsules. Through this collaboration, both Amneal Pharmaceuticals and Strides Pharma Science Limited aim to strengthen their cardiovascular product portfolio, broaden access to affordable omega-3 fatty acid therapy for patients with elevated triglyceride levels, and reinforce their presence in the U.S. generic specialty pharmaceuticals segment. Strides Pharma Science Limited is an India-based pharmaceutical company involved in the development, manufacturing, and commercialization of a broad range of pharmaceutical products.
Major companies operating in the gelatin capsule market are Lonza Group (Capsugel), Catalent Inc., Aenova Group GmbH, HBI Eurocaps Ltd. (Ourvita Group), ACG Worldwide Pvt. Ltd., Suheung Co. Ltd., Procaps Group, Sirio Pharma Co. Ltd., Qualicaps (Roquette), CapsCanada Corporation, Farmacápsulas S.A., Natural Capsules Ltd., Sunil Healthcare Ltd., Erawat Pharma Limited, HealthCaps India Ltd., Jinan Gaohua Pharmaceutical Capsules Co. Ltd., Fortcaps Healthcare Ltd., Jiangsu Lefan Capsule Co. Ltd., Shanxi Guangsheng Medicinal Capsule Co. Ltd., Qingdao Yiqing Medicinal Capsules Co. Ltd., Roxlor LLC, Medi-Caps Ltd.
Asia-Pacific was the dominant region in the gelatin capsule market in 2025 and is expected to be the rapidly expanding region in the forecast period. The regions covered in gelatin capsule report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the gelatin capsule market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The gelatin capsule market consists of sales of capsule shells, empty capsules, and vegetarian capsules (HPMC-based). Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The gelatin capsule market research report is one of a series of new reports that provides gelatin capsule market statistics, including gelatin capsule industry global market size, regional shares, competitors with a gelatin capsule market share, detailed gelatin capsule market segments, market trends and opportunities, and any further data you may need to thrive in the gelatin capsule industry. This gelatin capsule market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
This product will be delivered within 1-3 business days.
The gelatin capsule market size is expected to see strong growth in the next few years. It will grow to $7.01 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to increasing demand for nutraceuticals and functional food products, growing shift toward plant-based and vegan capsule alternatives, rising adoption of precision medicine and controlled-release formulations, expansion of global pharmaceutical manufacturing capacity, and increasing focus on drug stability and bioavailability enhancement. Key trends in the forecast period include transition toward plant-based capsule materials replacing animal-derived gelatin, increasing adoption of modified-release capsule technologies for targeted drug delivery, rising demand for nutraceutical and dietary supplement encapsulation, integration of advanced coating technologies for moisture and oxygen protection, and growing use of high bioavailability capsule formulations in personalized medicine.
The growth of the pharmaceutical industry is expected to propel the growth of the gelatin capsule market going forward. The pharmaceutical industry refers to the sector involved in the research, development, production, and marketing of drugs used for medical treatment, prevention, and diagnosis of diseases. The expansion of the pharmaceutical industry is driven by the increasing prevalence of chronic and lifestyle-related diseases, which leads to higher demand for continuous drug development and treatment solutions. The pharmaceutical industry utilizes gelatin capsules as a reliable drug delivery system that improves stability, enhances bioavailability, ensures precise dosing, and increases patient compliance by making medicines easier to swallow and masking unpleasant tastes and odors. For instance, in April 2025, according to Eurostat, a Luxembourg-based government agency, in 2024, EU exports of medicinal and pharmaceutical products increased by 13.5% compared with 2023, reaching $316.38 billion (€313.4 billion). At the same time, imports only recorded a modest increase of 0.5%, amounting to $112.7 billion (€119.7 billion). Therefore, the pharmaceutical industry is driving the growth of the gelatin capsule market.
Leading companies operating in the gelatin capsule market are focusing on developing innovative products, such as soft gelatin capsules to improve bioavailability, enhance patient compliance, and enable easier administration of medications across all age groups. Gelatin capsules are edible, biodegradable pharmaceutical dosage forms made from animal-derived gelatin or plant-based alternatives, designed to encapsulate liquid, semi-solid, or powdered drug formulations in a smooth, swallowable shell that dissolves rapidly in the digestive tract for efficient drug release. For example, in August 2024, Geneith Pharmaceuticals Limited, a Nigeria-based pharmaceutical company, launched Coatal Forte Soft Gelatin Capsules, a patient-friendly antimalarial formulation designed to improve treatment accessibility and effectiveness. The product is available in multiple strengths, including Coatal Gelatin Soft Gel 80/480 and 20/120, offering flexible dosing options to suit different patient needs. It is formulated to ensure faster drug delivery and improved therapeutic outcomes while maintaining affordability and ease of use, making it suitable for patients across all age groups and supporting better compliance in malaria treatment regimens.
In December 2023, Amneal Pharmaceuticals Inc., a US-based specialty pharmaceutical company engaged in gelatin capsule manufacturing, entered into a partnership with Strides Pharma Science Limited to jointly develop, manufacture, and supply icosapent ethyl acid soft gelatin capsules. Through this collaboration, both Amneal Pharmaceuticals and Strides Pharma Science Limited aim to strengthen their cardiovascular product portfolio, broaden access to affordable omega-3 fatty acid therapy for patients with elevated triglyceride levels, and reinforce their presence in the U.S. generic specialty pharmaceuticals segment. Strides Pharma Science Limited is an India-based pharmaceutical company involved in the development, manufacturing, and commercialization of a broad range of pharmaceutical products.
Major companies operating in the gelatin capsule market are Lonza Group (Capsugel), Catalent Inc., Aenova Group GmbH, HBI Eurocaps Ltd. (Ourvita Group), ACG Worldwide Pvt. Ltd., Suheung Co. Ltd., Procaps Group, Sirio Pharma Co. Ltd., Qualicaps (Roquette), CapsCanada Corporation, Farmacápsulas S.A., Natural Capsules Ltd., Sunil Healthcare Ltd., Erawat Pharma Limited, HealthCaps India Ltd., Jinan Gaohua Pharmaceutical Capsules Co. Ltd., Fortcaps Healthcare Ltd., Jiangsu Lefan Capsule Co. Ltd., Shanxi Guangsheng Medicinal Capsule Co. Ltd., Qingdao Yiqing Medicinal Capsules Co. Ltd., Roxlor LLC, Medi-Caps Ltd.
Asia-Pacific was the dominant region in the gelatin capsule market in 2025 and is expected to be the rapidly expanding region in the forecast period. The regions covered in gelatin capsule report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the gelatin capsule market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The gelatin capsule market consists of sales of capsule shells, empty capsules, and vegetarian capsules (HPMC-based). Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The gelatin capsule market research report is one of a series of new reports that provides gelatin capsule market statistics, including gelatin capsule industry global market size, regional shares, competitors with a gelatin capsule market share, detailed gelatin capsule market segments, market trends and opportunities, and any further data you may need to thrive in the gelatin capsule industry. This gelatin capsule market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Gelatin Capsule Market Characteristics
3. Gelatin Capsule Market Supply Chain Analysis
4. Global Gelatin Capsule Market Trends And Strategies
5. Gelatin Capsule Market Analysis Of End Use Industries
7. Global Gelatin Capsule Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
8. Global Gelatin Capsule Total Addressable Market (TAM) Analysis for the Market
9. Gelatin Capsule Market Segmentation
10. Gelatin Capsule Market Regional And Country Analysis
11. Asia-Pacific Gelatin Capsule Market
12. China Gelatin Capsule Market
13. India Gelatin Capsule Market
14. Japan Gelatin Capsule Market
15. Australia Gelatin Capsule Market
16. Indonesia Gelatin Capsule Market
17. South Korea Gelatin Capsule Market
18. Taiwan Gelatin Capsule Market
19. South East Asia Gelatin Capsule Market
20. Western Europe Gelatin Capsule Market
21. UK Gelatin Capsule Market
22. Germany Gelatin Capsule Market
23. France Gelatin Capsule Market
24. Italy Gelatin Capsule Market
25. Spain Gelatin Capsule Market
26. Eastern Europe Gelatin Capsule Market
27. Russia Gelatin Capsule Market
28. North America Gelatin Capsule Market
29. USA Gelatin Capsule Market
30. Canada Gelatin Capsule Market
31. South America Gelatin Capsule Market
32. Brazil Gelatin Capsule Market
33. Middle East Gelatin Capsule Market
34. Africa Gelatin Capsule Market
36. Gelatin Capsule Market Competitive Landscape And Company Profiles
37. Gelatin Capsule Market Other Major And Innovative Companies
41. Gelatin Capsule Market High Potential Countries, Segments and Strategies
42. Appendix
Executive Summary
Gelatin Capsule Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses gelatin capsule market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for gelatin capsule? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gelatin capsule market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Hard Gelatin Capsules; Soft Gelatin Capsules2) By Raw Materials: Bovine Gelatin; Porcine Gelatin; Other Raw Materials
3) By Function: Gelling Agent; Stabilizer And Thickener; Binding And Texturizing Agent
4) By Application: Nutraceutical; Pharmaceutical
Subsegments:
1) By Hard Gelatin Capsules: Two Piece Capsules; Delayed Release Capsules; Enteric Coated Capsules2) By Soft Gelatin Capsules: Liquid Filled Capsules; Semi Solid Filled Capsules; Chewable Soft Capsules; Suspension Based Capsules
Companies Mentioned: Lonza Group (Capsugel); Catalent Inc.; Aenova Group GmbH; HBI Eurocaps Ltd. (Ourvita Group); ACG Worldwide Pvt. Ltd.; Suheung Co. Ltd.; Procaps Group; Sirio Pharma Co. Ltd.; Qualicaps (Roquette); CapsCanada Corporation; Farmacápsulas S.A.; Natural Capsules Ltd.; Sunil Healthcare Ltd.; Erawat Pharma Limited; HealthCaps India Ltd.; Jinan Gaohua Pharmaceutical Capsules Co. Ltd.; Fortcaps Healthcare Ltd.; Jiangsu Lefan Capsule Co. Ltd.; Shanxi Guangsheng Medicinal Capsule Co. Ltd.; Qingdao Yiqing Medicinal Capsules Co. Ltd.; Roxlor LLC; Medi-Caps Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
- Lonza Group (Capsugel)
- Catalent Inc.
- Aenova Group GmbH
- HBI Eurocaps Ltd. (Ourvita Group)
- ACG Worldwide Pvt. Ltd.
- Suheung Co. Ltd.
- Procaps Group
- Sirio Pharma Co. Ltd.
- Qualicaps (Roquette)
- CapsCanada Corporation
- Farmacápsulas S.A.
- Natural Capsules Ltd.
- Sunil Healthcare Ltd.
- Erawat Pharma Limited
- HealthCaps India Ltd.
- Jinan Gaohua Pharmaceutical Capsules Co. Ltd.
- Fortcaps Healthcare Ltd.
- Jiangsu Lefan Capsule Co. Ltd.
- Shanxi Guangsheng Medicinal Capsule Co. Ltd.
- Qingdao Yiqing Medicinal Capsules Co. Ltd.
- Roxlor LLC
- Medi-Caps Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | April 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.27 Billion |
| Forecasted Market Value ( USD | $ 7.01 Billion |
| Compound Annual Growth Rate | 7.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
